Liver i-BiopsyTM and the corresponding intelligent fibrosis scoring systems: I-Metavir F and i-Ishak F

1Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

An important goal of modern medicine is to replace invasive, painful procedures with non-invasive techniques for diagnosis. We investigated the possibility of a knowledge discovery in data approach, based on computational intelligence tools, to integrate information from various data sources - imaging data, clinical and laboratory data, to predict with acceptable accuracy the results of the biopsy. The resulted intelligent systems, tested on 700 patients with chronic hepatitis C, based on C5.0 decision trees and boosting, predict with 100% accuracy the fibrosis stage results of the liver biopsy, according to two largely accepted fibrosis scoring systems, Metavir and Ishak, with and without liver stiffness (FibroScan®). We also introduced the concepts of intelligent virtual biopsy or i-BiopsyTMand that of i-scores. To our best knowledge i-BiopsyTMoutperformed all similar systems published in the literature and offer a realistic opportunity to replace liver biopsy in many important medical contexts. © 2009 Springer Berlin Heidelberg.

Cite

CITATION STYLE

APA

Floares, A. G. (2009). Liver i-BiopsyTM and the corresponding intelligent fibrosis scoring systems: I-Metavir F and i-Ishak F. In Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) (Vol. 5488 LNBI, pp. 253–264). https://doi.org/10.1007/978-3-642-02504-4_23

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free